Shree Pacetronix Ltd
Incorporated in 1988, Shree Pacetronix Ltd manufactures and exports Implantable Cardiac Pacemakers.
- Market Cap ₹ 95.4 Cr.
- Current Price ₹ 265
- High / Low ₹ 283 / 61.1
- Stock P/E 40.6
- Book Value ₹ 44.2
- Dividend Yield 0.00 %
- ROCE 9.03 %
- ROE 5.54 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 24.2%
- Company has high debtors of 166 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.11 | 6.49 | 7.40 | 6.84 | 6.60 | 7.27 | 8.76 | 7.56 | 9.03 | 20.19 | 22.04 | 16.68 | 19.84 | |
| 5.82 | 5.34 | 6.22 | 6.34 | 5.80 | 6.52 | 7.52 | 6.45 | 7.44 | 14.75 | 16.29 | 14.46 | 15.61 | |
| Operating Profit | 1.29 | 1.15 | 1.18 | 0.50 | 0.80 | 0.75 | 1.24 | 1.11 | 1.59 | 5.44 | 5.75 | 2.22 | 4.23 |
| OPM % | 18.14% | 17.72% | 15.95% | 7.31% | 12.12% | 10.32% | 14.16% | 14.68% | 17.61% | 26.94% | 26.09% | 13.31% | 21.32% |
| 0.01 | -0.15 | -0.08 | 0.05 | 0.01 | 0.17 | 0.04 | 0.05 | 0.07 | 0.09 | 0.14 | 0.12 | 0.10 | |
| Interest | 0.46 | 0.41 | 0.35 | 0.38 | 0.31 | 0.30 | 0.36 | 0.34 | 0.28 | 0.30 | 0.45 | 0.60 | 0.50 |
| Depreciation | 0.51 | 0.68 | 0.69 | 0.57 | 0.39 | 0.38 | 0.51 | 0.51 | 0.50 | 0.63 | 0.82 | 0.70 | 0.70 |
| Profit before tax | 0.33 | -0.09 | 0.06 | -0.40 | 0.11 | 0.24 | 0.41 | 0.31 | 0.88 | 4.60 | 4.62 | 1.04 | 3.13 |
| Tax % | 33.33% | -66.67% | 116.67% | -27.50% | 36.36% | 41.67% | 31.71% | 41.94% | 26.14% | 29.35% | 27.49% | 26.92% | |
| 0.22 | -0.04 | -0.01 | -0.29 | 0.08 | 0.14 | 0.28 | 0.18 | 0.65 | 3.25 | 3.36 | 0.75 | 2.35 | |
| EPS in Rs | 0.61 | -0.11 | -0.03 | -0.81 | 0.22 | 0.39 | 0.78 | 0.50 | 1.81 | 9.03 | 9.33 | 2.08 | 6.53 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 23% |
| TTM: | -24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 23% |
| 3 Years: | 6% |
| TTM: | 5% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 86% |
| 3 Years: | 26% |
| 1 Year: | 110% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 18% |
| 3 Years: | 22% |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 | 3.60 |
| Reserves | 1.88 | 1.81 | 1.80 | 1.51 | 1.70 | 1.84 | 2.11 | 2.30 | 2.95 | 6.20 | 9.56 | 10.31 | 12.29 |
| 2.08 | 2.69 | 1.89 | 2.64 | 2.30 | 2.94 | 2.64 | 2.73 | 2.88 | 2.16 | 4.27 | 4.97 | 4.94 | |
| 1.27 | 0.95 | 1.31 | 1.28 | 1.29 | 1.27 | 1.99 | 2.07 | 2.62 | 4.64 | 4.39 | 4.16 | 4.60 | |
| Total Liabilities | 8.83 | 9.05 | 8.60 | 9.03 | 8.89 | 9.65 | 10.34 | 10.70 | 12.05 | 16.60 | 21.82 | 23.04 | 25.43 |
| 3.10 | 2.89 | 2.40 | 1.94 | 1.84 | 2.36 | 2.43 | 2.65 | 2.51 | 3.07 | 3.60 | 3.34 | 3.63 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.77 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.51 |
| Investments | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
| 4.93 | 5.36 | 5.40 | 5.52 | 6.25 | 6.49 | 7.00 | 7.25 | 8.74 | 12.73 | 17.42 | 18.90 | 20.49 | |
| Total Assets | 8.83 | 9.05 | 8.60 | 9.03 | 8.89 | 9.65 | 10.34 | 10.70 | 12.05 | 16.60 | 21.82 | 23.04 | 25.43 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.13 | 0.36 | 1.32 | 0.57 | 0.08 | 0.63 | 1.49 | 0.99 | 0.59 | 2.40 | -0.03 | 0.05 | |
| -0.44 | -0.49 | -0.21 | -0.89 | 0.45 | -0.75 | -0.56 | -0.58 | -1.10 | -1.41 | -1.67 | -0.03 | |
| -0.90 | 0.19 | -1.11 | 0.24 | -0.48 | 0.26 | -0.81 | -0.15 | -0.14 | -0.96 | 1.75 | 0.12 | |
| Net Cash Flow | -0.21 | 0.07 | 0.00 | -0.07 | 0.06 | 0.14 | 0.12 | 0.26 | -0.65 | 0.03 | 0.05 | 0.14 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 91.38 | 64.68 | 78.92 | 102.46 | 174.20 | 154.13 | 162.50 | 194.57 | 209.78 | 108.65 | 96.22 | 165.87 |
| Inventory Days | 484.22 | 746.59 | 359.32 | 373.73 | 301.93 | 270.24 | 217.26 | 272.02 | 194.20 | 157.41 | 285.83 | 463.17 |
| Days Payable | 40.35 | 33.18 | 32.67 | 27.63 | 48.31 | 33.93 | 53.23 | 47.19 | 17.55 | 32.22 | 12.45 | 57.32 |
| Cash Conversion Cycle | 535.25 | 778.09 | 405.57 | 448.55 | 427.83 | 390.45 | 326.53 | 419.40 | 386.43 | 233.84 | 369.59 | 571.72 |
| Working Capital Days | 82.65 | 96.17 | 104.07 | 90.72 | 139.36 | 104.93 | 83.33 | 98.01 | 108.73 | 86.05 | 120.23 | 180.31 |
| ROCE % | 10.28% | 3.83% | 5.33% | -0.40% | 5.47% | 5.13% | 9.09% | 7.54% | 12.51% | 45.82% | 34.50% | 9.03% |
Documents
Announcements
-
Submission Of Unaudited Financial Results (Standalone And Consolidated) Along With Limited Review Report For The Quarter And Half Year Ended 30Th September, 2025.
3h - Unaudited Q2/H1 results ended 30 Sep 2025; H1 revenue Rs1,198.53 lakh, PBT Rs265.37 lakh.
-
Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday, 01St November, 2025
3h - Approved unaudited standalone and consolidated results for quarter/H1 ended 30 Sep 2025; limited review unmodified.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - We are in receipt of enclosed Pre-Offer Advertisement of offer issued by Vivro Financial Services Private Limited in relation to the Open Offer to the …
-
Pre-Offer Advertisement
2d - Acquirer to buy up to 9,75,000 shares (26%) of Shree Pacetronix at Rs100; tendering Oct 31–Nov 14, 2025.
-
Recommendations of Committee of Independent Directors ('IDC')
28 Oct - Promoter open offer to acquire 9,75,000 shares (26%) at Rs.100 each; IDC recommends fair; dated Oct 27, 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Profile:[1][2]
Company deals in 3 major products viz, Pacemakers, Pacing Leads, Pacing System which are further bifurcated as: Ventralite 940+/ Tiranga, Pinnacle-8820, Tiranga -302, Pinnacle-R-SSIR-Model-29, Trinity-R, Smart - E, Atrial-J-Bipolar-Lead-3851-VB, Introducer, Zeus -1, Is1 Bipolar Lead 3851 Vb, Screw-in Lead P12, Pace Maker Analyser, Charak DDDR, Indus I SSB, Implantable Cardioverter Pacemaker, Single Chamber Pacemaker, Reuters Pacemakers, Permanent Pacemaker, Medtronic Pacemaker, Pacing System Analyzer